Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Multimodality Therapy for Oligometastatic Prostate Cancer
NCT02716974Phase 2Completed
- Sponsor
- Sidney Kimmel Comprehensive Cancer Center
- Start
- Jun 2016
- Primary completion
- Apr 2022
- Modality
- Peptides, Small Molecules
- Countries
- 1
01
Overview
A Phase 2 trial of docetaxel, leuprolide, bicalutamide in prostate cancer (PCa), sponsored by Sidney Kimmel Comprehensive Cancer Center. Started Jun 2016; status: completed.
02
Drugs
docetaxelleuprolidebicalutamide
03
Conditions
prostate cancer (PCa)
Beyond the preview
Go deeper on NCT02716974.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT02716974.